Type of Cancer
Phase
Division (Location)
Study ID
NCT#
Brief Description
Randomized phase 2 trial of gemcitabine + carboplatin + nivolumab versus gemcitabine + oxaliplatin + nivolumab in cisplatin-ineligible patients with metastatic urothelial cancer
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.